A Glowing Endorsement

I would like to congratulate the Leukaemia Foundation of Australia for this important initiative and fully endorse their efforts to provide much needed accommodation for patients and their families.

The construction of the fantastic new facility for cancer care opposite and incorporating The Royal Melbourne Hospital at Parkville represents an extraordinary opportunity to enhance the clinical care and research for patients diagnosed with blood conditions.

The haematology service which will occupy those buildings will be a state of-the-art haematology service provided by expert medical and nursing teams from Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. As two key members of the Victorian Comprehensive Cancer Centre, the Haematology Services of The Royal Melbourne Hospital and Peter MacCallum Cancer Centre already attract and care for patients and their families from all around Victoria and interstate. The Bone Marrow Transplant Service of The Royal Melbourne Hospital cares for patients throughout Victoria and for patients requiring transplantation from Tasmania and from southern NSW. Similarly, patients with blood cancers including leukaemia, myeloma and lymphoma frequently travel long distances for the care provided in metropolitan Melbourne. 

Often, protracted periods of outpatient monitoring is required, preventing patients from returning to their homes immediately even though they may have been discharged from inpatient care. Similarly, for the families of patients requiring inpatient care, having somewhere to stay locally significantly eases their burden and provides much needed family support for patients admitted to hospital.

 

The Leukaemia Foundation of Australia is a critical resource for patients diagnosed with blood conditions. It provides an extraordinary level of information, education and practical support for patients and their families while they undergo often difficult, complex therapies. The Leukaemia Foundation is to be congratulated in their efforts to extend their support to these families by providing local accommodation in the form of 15 purpose-built apartments which will be closely located to the new cancer care facilities in Parkville. 

I would like to congratulate LFA for this important initiative and fully endorse their efforts to provide much needed accommodation for patients and their families. Without support such as this, it would be impossible for the clinical teams to deliver safe and effective care to patients, particularly those who are far from home. The close integration of community support networks such as LFA with hospital based clinical teams is a shining example of the way in which clinical care can be optimised and the burden of treatment reduced as much as possible. 

Yours sincerely,

David Ritchie

Director
Bone Marrow Transplant Service

Deputy Director
Clinical Haematology and BMT